Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
7
currently held
Exits tracked
7
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capital
Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks agoCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminLauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month agoBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin11 companies matching
| Company | Sector | Geo | Investor | Entry | Hold | Status | Buyer | MOIC | |
|---|---|---|---|---|---|---|---|---|---|
Duomed Group G Square Capital II | G Square Healthcare PE | 2017 | 7yr | Exited 2024 | Palex Medical | – | |||
iSTAR Medical2 periods Earlybird Health | Earlybird Venture Capital | 2019 | 7yr | Active | – | – | |||
Multiplicom Gimv Portfolio | Gimv | – | – | Exited 2016 | Agilent Technologies | – | |||
Endosense3 periods BioDiscovery 3 | Andera Partners | 2009 | 4yr | Exited 2013 | St. Jude Medical | – | |||
V!go Waterland Private Equity Fund III (WPEF III) | Waterland Private Equity | 2007 | 4yr | Exited 2011 | Pentahold | – | |||
CryoTherapeutics2 periods Creathor Venture Fund III | Creathor Ventures | 2009 | 17yr | Active | – | – | |||
Miracor Medical SHS III | SHS Gesellschaft für Beteiligungsmanagement | 2011 | 15yr | Active | – | – | |||
Nyxoah BioDiscovery 5 | Andera Partners | 2020 | 6yr | Active | – | – | |||
SamanTree Medical SA Capital Santé 2 | Turenne Groupe | 2024 | 2yr | Active | – | – | |||
FOx Biosystems EMV Capital Evergreen Fund | EMV Capital | 2020 | 6yr | Active | – | – | |||
Nobi Angelini Ventures | Angelini Ventures | 2025 | 1yr | Active | – | – |
Duomed Group
G Square Capital II
BelgiumSector
MedTech
InvestorG Square Healthcare PE
Entry
2017
Hold
7yr
Exit
2024
to Palex Medical
iSTAR Medical
Earlybird Health
BelgiumSector
MedTech
InvestorEarlybird Venture Capital
Entry
2019
Hold
7yr
Owners
2
Multiplicom
Gimv Portfolio
BelgiumSector
MedTech
InvestorGimv
Entry
–
Exit
2016
to Agilent Technologies
Endosense
BioDiscovery 3
BelgiumSector
MedTech
InvestorAndera Partners
Entry
2009
Hold
4yr
Owners
3
Exit
2013
to St. Jude Medical
V!go
Waterland Private Equity Fund III (WPEF III)
BelgiumSector
MedTech
InvestorWaterland Private Equity
Entry
2007
Hold
4yr
Exit
2011
to Pentahold
CryoTherapeutics
Creathor Venture Fund III
BelgiumSector
MedTech
InvestorCreathor Ventures
Entry
2009
Hold
17yr
Owners
2
Miracor Medical
SHS III
BelgiumSector
MedTech
InvestorSHS Gesellschaft für Beteiligungsmanagement
Entry
2011
Hold
15yr
Nyxoah
BioDiscovery 5
BelgiumSector
MedTech
InvestorAndera Partners
Entry
2020
Hold
6yr
SamanTree Medical SA
Capital Santé 2
BelgiumSector
MedTech
InvestorTurenne Groupe
Entry
2024
Hold
2yr
FOx Biosystems
EMV Capital Evergreen Fund
BelgiumSector
MedTech
InvestorEMV Capital
Entry
2020
Hold
6yr
Nobi
Angelini Ventures
BelgiumSector
MedTech
InvestorAngelini Ventures
Entry
2025
Hold
1yr